Bariatric surgery: an IDF statement for obese Type 2 diabetes
2011

Bariatric Surgery for Type 2 Diabetes

Sample size: 2037 publication Evidence: high

Author Information

Author(s): J B Dixon, P Zimmet, K G Alberti, F Rubino

Primary Institution: Baker IDI Heart and Diabetes Institute

Hypothesis

Can bariatric surgery improve glycaemic control in severely obese patients with Type 2 diabetes?

Conclusion

Bariatric surgery is an effective and cost-effective treatment for Type 2 diabetes in obese patients who do not achieve treatment targets with medical therapies.

Supporting Evidence

  • Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes.
  • 78.1% of patients had remission of diabetes following surgery.
  • 72% of patients achieved remission of diabetes at 2 years post-surgery.

Takeaway

Bariatric surgery can help people with obesity and diabetes get better control of their blood sugar and lose weight, making them healthier.

Methodology

The working group reviewed literature on bariatric surgery published between 1991 and 2010, synthesizing evidence for efficacy, safety, and cost-effectiveness.

Potential Biases

Potential biases in reporting outcomes and follow-up of cohorts.

Limitations

The review was limited by the quality of available literature and the lack of consistent definitions of diabetes remission.

Participant Demographics

Participants included severely obese patients with Type 2 diabetes, with a focus on those with a BMI of 35 kg/m2 or more.

Digital Object Identifier (DOI)

10.1111/j.1464-5491.2011.03306.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication